AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report)’s share price rose 0.8% on Wednesday. The stock traded as high as $12.16 and last traded at $12.00. 489,818 shares traded hands during trading, a decline of 37% from the average session volume of 782,133 shares. The stock had previously closed at $11.91.
AGF U.S. Market Neutral Anti-Beta Fund Stock Up 0.8%
The company has a market capitalization of $304.20 million, a price-to-earnings ratio of 17.67 and a beta of -0.65. The stock has a fifty day moving average price of $12.10 and a two-hundred day moving average price of $12.20.
Institutional Trading of AGF U.S. Market Neutral Anti-Beta Fund
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. CoreCap Advisors LLC purchased a new position in AGF U.S. Market Neutral Anti-Beta Fund in the 2nd quarter valued at about $36,000. Bank of New York Mellon Corp boosted its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 59.4% during the 1st quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock worth $380,000 after purchasing an additional 10,146 shares during the last quarter. Worth Asset Management LLC grew its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 20.5% during the first quarter. Worth Asset Management LLC now owns 30,472 shares of the company’s stock worth $425,000 after buying an additional 5,190 shares in the last quarter. PMV Capital Advisers LLC grew its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 14.0% during the first quarter. PMV Capital Advisers LLC now owns 246,621 shares of the company’s stock worth $3,443,000 after buying an additional 30,234 shares in the last quarter. Finally, Crescent Grove Advisors LLC acquired a new position in shares of AGF U.S. Market Neutral Anti-Beta Fund in the first quarter valued at approximately $6,614,000.
AGF U.S. Market Neutral Anti-Beta Fund Company Profile
The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.
Further Reading
- Five stocks we like better than AGF U.S. Market Neutral Anti-Beta Fund
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.
